NCT02721160 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Basinga P, Mayaka S, Condo J
Performance-based financing: the need for more research. Bull World Health Organ. 2011 Sep 1;89(9):698-9. doi: 10.2471/BLT.11.089912.
Hayes RJ, Bennett S
Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999 Apr;28(2):319-26. Review.
Institut de Statistiques et d'Études Économiques du Burundi (ISTEEBU), Ministère de la Santé Publique et de la Lutte contre le Sida [Burundi] (MSPLS), and ICF International
2012. Enquête Démographique et de Santé Burundi 2010 (DHS Burundi 2010, Final Report). Bujumbura, Burundi : ISTEEBU, MSPLS, et ICF International.
Kaiser R, Woodruff BA, Bilukha O, Spiegel PB, Salama P
Using design effects from previous cluster surveys to guide sample size calculation in emergency settings. Disasters. 2006 Jun;30(2):199-211.

Measuring and Understanding the Effects of a Performance Based Financing Scheme Applied to Nutrition Services in Burundi

Clinical trial NCT02721160 - References